期刊文献+

泛基因型直接抗病毒药物治疗慢性丙型肝炎肝硬化患者疗效及安全性分析 被引量:2

Pan-genotype direct antiviral drugs for treatment of patients with chronic hepatitis C and liver cirrhosis efficacy and safety analysis
下载PDF
导出
摘要 慢性丙型肝炎病毒(hepatitis C virus,HCV)感染是严重的全球公共卫生问题,据统计,在全球范围内大约有7100万例丙型肝炎感染者,我国约有1000万例HCV感染者[1-3]。慢性丙型肝炎是持续进展性疾病,如果不及时治疗,持续的慢性感染会导致肝纤维化,最终导致肝硬化,并增加与肝硬化相关的并发症的风险,尤其是失代偿期肝硬化和肝癌。目前已鉴定出HCV的6种主要基因型(genotype,GT)和67种亚型,其中GT-1型最常见(49.1%)[4]。
作者 张亚苹 王凤梅 Zhang Yaping;Wang Fengmei
出处 《实用器官移植电子杂志》 2021年第1期70-74,I0002,共6页 Practical Journal of Organ Transplantation(Electronic Version)
  • 相关文献

参考文献3

二级参考文献84

  • 1Lai Wei,Jia Shang,Yuanji Ma,Xiaoyuan Xu,Yan Huang,Yujuan Guan,Zhongping Duan,Wenhong Zhang,Zhiliang Gao,Mingxiang Zhang,Jun Li,Jidong Jia,Yongfeng Yang,Xiaofeng Wen,Maorong Wang,Zhansheng Jia,Bo Ning,Yongping Chen,Yue Qi,Jie Du,Jianning Jiang,Lixin Tong,Yao Xie,Jinzi JWu.Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C[J].Journal of Clinical and Translational Hepatology,2019,7(3):221-225. 被引量:13
  • 2Xiaoyuan Xu,Bo Feng,Yujuan Guan,Sujun Zheng,Jifang Sheng,Xingxiang Yang,Yuanji Ma,Yan Huang,Yi Kang,Xiaofeng Wen,Jun Li,Youwen Tan,Qing He,Qing Xie,Maorong Wang,Ping An,Guozhong Gong,Huimin Liu,Qin Ning,Rui Hua,Bo Ning,Wen Xie,Jiming Zhang,Wenxiang Huang,Yongfeng Yang,Minghua Lin,Yingren Zhao,Yanhong Yu,Jidong Jia,Dongliang Yang,Liang Chen,Yinong Ye,Yuemin Nan,Zuojiong Gong,Quan Zhang,Peng Hu,Fusheng Wang,Yongguo Li,Dongliang Li,Zhansheng Jia,Jinlin Hou,Chengwei Chen,Jinzi JWu,Lai Wei.Efficacy and Safety of All-oral,12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naive Noncirrhotic HCV Genotype 1 Patients:Results from a Phase 2/3 Clinical Trial in China[J].Journal of Clinical and Translational Hepatology,2019,7(3):213-220. 被引量:15
  • 3Mohammad Irshad,Dhananjay Singh Mankotia,Khushboo Irshad.An insight into the diagnosis and pathogenesis of hepatitis C virus infection[J].World Journal of Gastroenterology,2013,19(44):7896-7909. 被引量:56
  • 4Joerg Timm,Michael Roggendorf.Sequence diversity of hepatitis C virus: Implications for immune control and therapy[J].World Journal of Gastroenterology,2007,13(36):4807-4817. 被引量:5
  • 5V. D. HOPE,I. ERAMOVA,D. CAPURRO,M. C. DONOGHOE.Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association[J].Epidemiology and Infection.2013(2)
  • 6Gary L. Davis,Miriam J. Alter,Hashem El–Serag,Thierry Poynard,Linda W. Jennings.Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression[J].Gastroenterology.2010(2)
  • 7Sylvie Deuffic–Burban,Pierre Deltenre,Maria Buti,Tommaso Stroffolini,Julie Parkes,Nikolai Mühlberger,Uwe Siebert,Christophe Moreno,Angelos Hatzakis,William Rosenberg,Stefan Zeuzem,Philippe Mathurin.Predicted Effects of Treatment for HCV Infection Vary Among European Countries[J].Gastroenterology.2012(4)
  • 8Oliver G. Pybus,Eleanor Barnes,Rachel Taggart,Philippe Lemey,Peter V. Markov,Bouachan Rasachak,Bounkong Syhavong,Rattanaphone Phetsouvanah,Isabelle Sheridan,Isla S. Humphreys,Ling Lu,Paul N. Newton,Paul Klenerman.Genetic History of Hepatitis C Virus in East Asia. Journal of Virology . 2009
  • 9Lauer GM,Walker BD.Hepatitis C virus infection. New England Journal of Medicine, The . 2001
  • 10Daniel Lavanchy.The global burden of hepatitis C. Liver International . 2009

共引文献161

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部